Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Neuroinflammation|May 3, 2023
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MSValentina Pegoretti, Jan Bauer, Roman Fischer, et al.
CNS Neuroscience & Therapeutics|May 28, 2018
Therapeutic effects of dietary intervention on neuroinflammation and brain metabolism in a rat model of photothrombotic strokeEwelina Kurtys, Cindy Casteels, Caroline C Real, et al.
Scientific Reports|June 30, 2023
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegenerationNatalia Ortí-Casañ, Ate S Boerema, Karina Köpke, et al.
Brain, Behavior, and Immunity|March 26, 2016
Depression and markers of inflammation as predictors of all-cause mortality in heart failurePaula M C Mommersteeg, Regien G Schoemaker, Petrus J W Naudé, et al.
Scientific Reports|September 13, 2018
Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosisSarah K Williams, Richard Fairless, Olaf Maier, et al.
Behavioural Brain Research|October 19, 2013
Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient micePetrus J W Naude, Nikoletta Dobos, Dennis van der Meer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2012
Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's diseasePetrus J W Naudé, Csaba Nyakas, Lee E Eiden, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2011
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depressionNikoletta Dobos, Erik F J de Vries, Ido P Kema, et al.
Molecular and Cellular Neurosciences|November 3, 2004
Long-term NR2B expression in the cerebellum alters granule cell development and leads to NR2A down-regulation and motor deficitsKatalin Schlett, Isabelle Pieri, Friedrich Metzger, et al.
Neurobiology of Aging|August 8, 2021
Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementiaPetrus J W Naudé, Inez H G B Ramakers, Wiesje M van der Flier, et al.
Pageof 7